Technical breakthroughs in gene sequencing, protein analysis, and mathematical modeling are creating enormous opportunities to enhance human health. These technologies create an unprecedented challenge presented by the overwhelming amount of biologic data—increasingly about individuals rather than populations. Computational solutions are essential:
One example is the prediction of cardiac dysfunction in individuals receiving drug treatments and/or with underlying genetic predisposition to heart disease.
Genomics and Systems Biology ISP
Biomedical Genetics and Cancer Synergomics
Department of Computational and Systems Biology